glp 1 levothyroxine thyroid and Hepatic thyroid hormone signalling modulates glucose homeostasis through the regulation of GLP Schematic overview of the benefits
Description
GLP-1 medicines were first approved for treating Type 2 diabetes, a disease in which the body cant properly use or doesnt make enough insulin to control blood glucose levels, in 2005
In the SURMOUNT-2 trial [2] involving patients with type 2 diabetes, the weight loss was 14.7% at the highest dose
Liraglutide also suppresses food intake and body weight of high fat diet fed mice (Table 3) (Li et al., 2017
Back Moore, B (1 Jan 1906) 'On the treatment of Diabetes mellitus by acid extract of Duodenal Mucous Membrane', Biochemical Journal , 1/1, 28-38
11 Obesity contributes to an inflammatory state through adipokines and various pro-inflammatory cytokines 12 and is associated with higher risks of having active disease, 12 poorer surgical outcomes, 13 and impaired quality of life in IBD
